Lamellar Ichthyosis Epidemiology Forecast to 2030

Lamellar Ichthyosis Epidemiology Forecast to 2030

Delveinsight Business Research
DelveInsight’s ‘Lamellar Ichthyosis Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Lamellar Ichthyosis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Lamellar Ichthyosis (LI) is a rare genetic disorder, where skin cells are produced at a normal rate, but they do not separate normally at the surface of the outermost layer of skin and are not shed as quickly as they should be which lead to the formation of scale.

Infants affected with Lamellar Ichthyosis are born encased in a hyperkeratotic translucent membrane, known as collodion baby, and within 2-week, develop large, thick, brownish lamellar scales with minimal erythema. Additionally, Lamellar Ichthyosis is associated with crumpled ears, alopecia, eclabium, and ectropion.

It is mainly caused by the mutations affecting several different genes, the genes which mainly involved in Lamellar Ichthyosis include TGM1, ABCA12, CYP4F22, NIPAL4 and others like LIPN, ALOX12B. However, most of the cases (~90%) are caused due to mutation in the TGM1 gene.

The DelveInsight Lamellar Ichthyosis epidemiology report gives a thorough understanding of the Lamellar Ichthyosis by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. 

It also provides treatment algorithms and treatment guidelines for Lamellar Ichthyosis in the US, Europe, and Japan. The report covers the detailed information of the Lamellar Ichthyosis epidemiology scenario in seven major countries (US, EU5, and Japan).


Key Highlights Of The Report

  • Lamellar Ichthyosis is estimated to affect 1 in 100,000 individuals in the United States. This condition is more common in Norway, where an estimated range is 1 in 91,000 individuals. As per the British Association of Dermatologists, Lamellar Ichthyosis is a rare form occurring in 1 in 200,000 live births in the United Kingdom.

  • DelveInsight estimate that the total prevalent population of Lamellar Ichthyosis in the 7MM was 4,038 in 2017 for the study period [2017–2030].

  • Among the European 5 countries, Germany had the highest diagnosed prevalent population of Lamellar Ichthyosis with 222 cases in 2017, followed by France and the United Kingdom. On the other hand, Spain had the lowest diagnosed prevalent population of Lamellar Ichthyosis.

 Lamellar Ichthyosis Epidemiology

Request for Sample Pages:


Lamellar Ichthyosis Epidemiology

Delveinsight’s Lamellar Ichthyosis epidemiology division provides insights about historical and current patient pool and forecasted trends for every seven major countries. 

The Lamellar Ichthyosis epidemiology data are studied through all possible divisions to give a better understanding of the Disease scenario in 7MM. 

The Lamellar Ichthyosis epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2017 to 2030. 

It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.


Scope of the Report

  • The report provides insight into the historical and forecasted patient pool of Lamellar Ichthyosis in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan.

  • The report assesses the disease risk and burden and highlights the unmet needs of Lamellar Ichthyosis.

  • The report helps to recognize the growth opportunities in the 7MM with respect to the patient population.

  • The Lamellar Ichthyosis report provides a detailed overview explaining Lamellar Ichthyosis causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns.

  • The Lamellar Ichthyosis Epidemiology Report and Model provide an overview of the risk factors and global trends of Lamellar Ichthyosis in the seven major markets (7MM:US, France, Germany, Italy, Spain, UK, and Japan).

  • The report provides the segmentation of the Lamellar Ichthyosis epidemiology. 


Key Questions Covered In The Lamellar Ichthyosis Report Include:

  • What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Lamellar Ichthyosis?

  • What are the key findings pertaining to the Lamellar Ichthyosis epidemiology across 7MM and which country will have the highest number of patients during the forecast period (2017-2030)?

  • What would be the total number of patients of Lamellar Ichthyosis across the 7MM during the forecast period (2017-2030)?

  •  Among the EU5 countries, which country will have the highest number of patients during the forecast period (2017-2030)?

  • At what CAGR the patient population is expected to grow in 7MM during the forecast period (2017-2030)?

  • What is the disease risk, burden and unmet needs of the Lamellar Ichthyosis?

  • What are the currently available treatments of Lamellar Ichthyosis?


Key Benefit of Lamellar Ichthyosis Epidemiology Report 

  • The Lamellar Ichthyosis Epidemiology report will allow the user to –

  • Develop business strategies by understanding the trends shaping and driving the global Lamellar Ichthyosis market

  • Quantify patient populations in the global Lamellar Ichthyosis market to improve product design, pricing, and launch plans

  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Lamellar Ichthyosis therapeutics in each of the markets covered

  • Understand the magnitude of Lamellar Ichthyosis population by its epidemiology

  • The Lamellar Ichthyosis Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources


Table of Contents

  1. Key Insights 

  2. Executive Summary of Lamellar Ichthyosis

  3. Lamellar Ichthyosis Disease Background and Overview

  • Lamellar Ichthyosis Sign and Symptoms

  • Lamellar Ichthyosis Pathophysiology

  • Lamellar Ichthyosis Risk Factors

  • Lamellar Ichthyosis Diagnosis

  1. Lamellar Ichthyosis Patient Journey

  2. Lamellar Ichthyosis Epidemiology and Patient Population

  3. Lamellar Ichthyosis Treatment Algorithm, Current Treatment, and Medical Practices

  4. KOL Views on Lamellar Ichthyosis 

  5. Lamellar Ichthyosis Unmet Needs

  6. Appendix

  7. DelveInsight Capabilities

  8. Disclaimer

*The table of contents is not exhaustive; will be provided in the final report

About DelveInsight


DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.


Related Reports:

Lamellar Ichthyosis Market Insights, Epidemiology and Market Forecast 2030

Lamellar Ichthyosis Market Research Report presents a detailed analysis of the market listing Lamellar Ichthyosis Epidemiology, Drug therapies and pipeline for the study period from 2018-2030.


Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Anuj Rawat
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States